EdgarLookup

ALLSTATE CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that ALLSTATE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
59.3%
Profit Margin
Net income ÷ revenue
8.6%
Return on Assets
Net income ÷ assets
2.91x
Debt-to-Equity
Total liabilities ÷ equity
+0.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.35B Feb 20, 2026
FY2025 Sep 30, 2025 $17.26B Feb 20, 2026
FY2025 Jun 30, 2025 $16.63B Feb 20, 2026
FY2025 Mar 31, 2025 $16.45B Feb 20, 2026
FY2025 Dec 31, 2024 $16.51B Feb 20, 2026
FY2025 Sep 30, 2024 $16.63B Feb 20, 2026
FY2025 Jun 30, 2024 $15.71B Feb 20, 2026
FY2025 Mar 31, 2024 $15.26B Feb 20, 2026
FY2024 Dec 31, 2023 $14.83B Feb 24, 2025
FY2024 Sep 30, 2023 $14.50B Feb 24, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.28B Feb 20, 2026
FY2025 Dec 31, 2024 $4.67B Feb 20, 2026
FY2025 Dec 31, 2023 ($188.00M) Feb 20, 2026
FY2024 Dec 31, 2022 ($1.29B) Feb 24, 2025
FY2023 Dec 31, 2021 $1.61B Feb 21, 2024
FY2022 Dec 31, 2020 $5.58B Feb 16, 2023
FY2021 Dec 31, 2019 $4.85B Feb 18, 2022
FY2020 Dec 31, 2018 $2.16B Feb 22, 2021
FY2019 Dec 31, 2017 $3.55B Feb 21, 2020
FY2018 Dec 31, 2016 $1.88B Feb 15, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.11B Feb 20, 2026
FY2025 Dec 31, 2024 $8.93B Feb 20, 2026
FY2025 Dec 31, 2023 $4.23B Feb 20, 2026
FY2024 Dec 31, 2022 $5.12B Feb 24, 2025
FY2023 Dec 31, 2021 $5.12B Feb 21, 2024
FY2022 Dec 31, 2020 $5.49B Feb 16, 2023
FY2021 Dec 31, 2019 $5.13B Feb 18, 2022
FY2020 Dec 31, 2018 $5.18B Feb 22, 2021
FY2019 Dec 31, 2017 $4.31B Feb 21, 2020
FY2018 Dec 31, 2016 $3.99B Feb 15, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $228.00M Feb 20, 2026
FY2025 Dec 31, 2024 $210.00M Feb 20, 2026
FY2025 Dec 31, 2023 $267.00M Feb 20, 2026
FY2024 Dec 31, 2022 $420.00M Feb 24, 2025
FY2023 Dec 31, 2021 $345.00M Feb 21, 2024
FY2022 Dec 31, 2020 $308.00M Feb 16, 2023
FY2021 Dec 31, 2019 $433.00M Feb 18, 2022
FY2020 Dec 31, 2018 $277.00M Feb 22, 2021
FY2019 Dec 31, 2017 $299.00M Feb 21, 2020
FY2018 Dec 31, 2016 $313.00M Feb 15, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $119.76B Feb 20, 2026
FY2025 Dec 31, 2024 $111.62B Feb 20, 2026
FY2024 Dec 31, 2023 $103.36B Feb 24, 2025
FY2023 Dec 31, 2022 $97.99B Feb 21, 2024
FY2022 Dec 31, 2021 $99.44B Feb 16, 2023
FY2021 Dec 31, 2020 $125.99B Feb 18, 2022
FY2020 Dec 31, 2019 $119.95B Feb 22, 2021
FY2019 Dec 31, 2018 $112.25B Feb 21, 2020
FY2018 Dec 31, 2017 $112.42B Feb 15, 2019
FY2017 Dec 31, 2016 $108.61B Feb 26, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $89.17B Feb 20, 2026
FY2025 Dec 31, 2024 $90.25B Feb 20, 2026
FY2024 Dec 31, 2023 $85.73B Feb 24, 2025
FY2023 Dec 31, 2022 $80.63B Feb 21, 2024
FY2022 Dec 31, 2021 $74.31B Feb 16, 2023
FY2021 Dec 31, 2020 $95.77B Feb 18, 2022
FY2020 Dec 31, 2019 $93.95B Feb 22, 2021
FY2019 Dec 31, 2018 $90.94B Feb 21, 2020
FY2018 Dec 31, 2017 $89.87B Feb 15, 2019
FY2017 Dec 31, 2016 $88.04B Feb 26, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $30.61B Feb 20, 2026
FY2025 Dec 31, 2024 $21.44B Feb 20, 2026
FY2025 Dec 31, 2023 $17.77B Feb 20, 2026
FY2023 Dec 31, 2022 $17.49B Feb 21, 2024
FY2023 Dec 31, 2021 $24.94B Feb 21, 2024
FY2022 Dec 31, 2020 $30.22B Feb 16, 2023
FY2021 Dec 31, 2019 $26.00B Feb 18, 2022
FY2020 Dec 31, 2018 $21.31B Feb 22, 2021
FY2019 Dec 31, 2017 $22.55B Feb 21, 2020
FY2018 Dec 31, 2016 $20.57B Feb 15, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.12B Feb 20, 2026
FY2025 Dec 31, 2024 $3.25B Feb 20, 2026
FY2024 Dec 31, 2023 $3.50B Feb 24, 2025
FY2023 Dec 31, 2022 $3.50B Feb 21, 2024
FY2022 Dec 31, 2021 $3.50B Feb 16, 2023
FY2021 Dec 31, 2020 $2.37B Feb 18, 2022
FY2020 Dec 31, 2019 $2.55B Feb 22, 2021
FY2019 Dec 31, 2018 $2.53B Feb 21, 2020
FY2018 Dec 31, 2017 $2.18B Feb 15, 2019
FY2017 Dec 31, 2016 $1.22B Feb 26, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $62.39B Feb 20, 2026
FY2025 Dec 31, 2024 $53.29B Feb 20, 2026
FY2024 Dec 31, 2023 $49.72B Feb 24, 2025
FY2023 Dec 31, 2022 $50.97B Feb 21, 2024
FY2022 Dec 31, 2021 $53.29B Feb 16, 2023
FY2021 Dec 31, 2020 $52.77B Feb 18, 2022
FY2020 Dec 31, 2019 $48.07B Feb 22, 2021
FY2019 Dec 31, 2018 $44.03B Feb 21, 2020
FY2018 Jun 30, 2018 $2.92B Feb 15, 2019
FY2018 Dec 31, 2017 $43.16B Feb 15, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.49B Feb 20, 2026
FY2025 Dec 31, 2024 $8.09B Feb 20, 2026
FY2024 Dec 31, 2023 $7.94B Feb 24, 2025
FY2023 Dec 31, 2022 $7.96B Feb 21, 2024
FY2022 Dec 31, 2021 $7.98B Feb 16, 2023
FY2021 Dec 31, 2020 $7.83B Feb 18, 2022
FY2020 Dec 31, 2019 $6.63B Feb 22, 2021
FY2019 Dec 31, 2018 $6.45B Feb 21, 2020
FY2018 Dec 31, 2017 $6.35B Feb 15, 2019
FY2017 Dec 31, 2016 $6.35B Feb 26, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 14 Feb 20, 2026
FY2025 Sep 30, 2025 14 Feb 20, 2026
FY2025 Jun 30, 2025 7 Feb 20, 2026
FY2025 Mar 31, 2025 2 Feb 20, 2026
FY2025 Dec 31, 2024 7 Feb 20, 2026
FY2025 Sep 30, 2024 4 Feb 20, 2026
FY2025 Jun 30, 2024 1 Feb 20, 2026
FY2025 Mar 31, 2024 4 Feb 20, 2026
FY2024 Dec 31, 2023 5 Feb 24, 2025
FY2024 Sep 30, 2023 0 Feb 24, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 14 Feb 20, 2026
FY2025 Sep 30, 2025 13 Feb 20, 2026
FY2025 Jun 30, 2025 7 Feb 20, 2026
FY2025 Mar 31, 2025 2 Feb 20, 2026
FY2025 Dec 31, 2024 7 Feb 20, 2026
FY2025 Sep 30, 2024 4 Feb 20, 2026
FY2025 Jun 30, 2024 1 Feb 20, 2026
FY2025 Mar 31, 2024 4 Feb 20, 2026
FY2024 Dec 31, 2023 5 Feb 24, 2025
FY2024 Sep 30, 2023 0 Feb 24, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 260.00M Feb 20, 2026
FY2025 Dec 31, 2024 265.00M Feb 20, 2026
FY2024 Dec 31, 2023 262.00M Feb 24, 2025
FY2023 Dec 31, 2022 263.00M Feb 21, 2024
FY2022 Dec 31, 2021 281.00M Feb 16, 2023
FY2021 Dec 31, 2020 304.00M Feb 18, 2022
FY2020 Dec 31, 2019 319.00M Feb 22, 2021
FY2019 Dec 31, 2018 332.00M Feb 21, 2020
FY2018 Dec 31, 2017 355.00M Feb 15, 2019
FY2017 Dec 31, 2016 366.00M Feb 26, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.04B Feb 20, 2026
FY2025 Dec 31, 2024 $962.00M Feb 20, 2026
FY2025 Dec 31, 2023 $925.00M Feb 20, 2026
FY2024 Dec 31, 2022 $926.00M Feb 24, 2025
FY2023 Dec 31, 2021 $885.00M Feb 21, 2024
FY2022 Dec 31, 2020 $668.00M Feb 16, 2023
FY2021 Dec 31, 2019 $653.00M Feb 18, 2022
FY2020 Dec 31, 2018 $614.00M Feb 22, 2021
FY2019 Dec 31, 2017 $525.00M Feb 21, 2020
FY2018 Dec 31, 2016 $486.00M Feb 15, 2019